Menu

Neural Reward System Activity Varies Throughout the Day

The human brain is more responsive to rewards received in the morning or evening than in the afternoon, researchers find.

Nov 1, 2017
Catherine Offord

NEURAL SLUMP: The brain is less responsive to rewards received in the afternoon, compared with morning or evening, a study suggests.© ISTOCK.COM/G-STOCKSTUDIO

EDITOR'S CHOICE IN NEUROSCIENCE

The paper
J.E.M. Byrne et al., “Time of day differences in neural reward functioning in healthy young men,” J Neurosci, 37:8895-900, 2017.

Afternoon delight?
People report being happiest in the early afternoon. One idea is that the brain’s mood-influencing reward system varies diurnally for evolutionary reasons. According to this hypothesis, “at certain times of day, we’re more likely to want to engage with the environment,” says psychologist Jamie Byrne of Swinburne University of Technology in Australia. As hunters with poor night vision, we’d have “our best chance of catching Bambi . . . at about two in the afternoon.”

Cash for BOLD
To look for diurnal changes in reward functioning, Byrne and colleagues had 16 men guess the correct value of a concealed card in exchange for cash toward a prize. The researchers used blood oxygen level-dependent (BOLD) fMRI to monitor participants’ neural responses during this task at three times: 10 a.m., 2 p.m., and 7 p.m.

Sensory surprise
Counterintuitively, correct guesses elicited more activity in the brain’s reward regions, particularly the left putamen, in the morning or evening than in the afternoon. Byrne notes that while the results conflict with the standard evolutionary theory, they parallel modern humans’ familiar afternoon dip in motivation. “We think it’s about prediction error. Since the brain expects to get rewards at 2 p.m., it’s not really surprised when it does get them. When you get those rewards at 10 a.m. or 7 p.m., the brain is figuring out what’s happening.”

Timely responses
Why these fluctuations occur is unclear, University of Cambridge neuroscientist Wolfram Schultz writes in an email. But the results suggest that “maybe future studies should mention at what time of day they did such measurements,” he notes, “and keep the same time of experimentation when averaging data from different test subjects.”

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
NRGene has launched a new product that aims to empower breeding and maximize agricultural yield as part of the Denovo assembly product suite offered by the company.
Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
Scientists presented more than 30 abstracts featuring Bio-Rad’s Droplet Digital PCR (ddPCR) technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31–June 4.